On Nov. 5, 2021, Resverlogix announced that it had entered into a cooperation agreement with the Supreme Council of the Arab-African Economy which had expressed an interest in providing necessary investments and partnerships to support the entry of Resverlogixﾒs first-in-class drug ﾖ apabetalone into the Arab-African Economy.